InsiderTrades.com logo

ACRS Insider Trading

Insider Ownership Percentage: 5.60%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Aclaris Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Aclaris Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aclaris Therapeutics Share Price & Price History

Current Price: $3.01
Price Change: ▲ Price Increase of +0.23 (8.27%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for ACRS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Aclaris Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/19/2024Anand MehraDirectorBuy666,666$2.25$1,499,998.50710,030View SEC Filing Icon  
7/30/2024Braden Michael LeonardMajor ShareholderBuy173,730$1.30$225,849.0013,776,421View SEC Filing Icon  
7/22/2024Braden Michael LeonardMajor ShareholderBuy17,716$1.33$23,562.2813,602,691View SEC Filing Icon  
7/18/2024Braden Michael LeonardMajor ShareholderBuy130,317$1.30$169,412.1013,578,286View SEC Filing Icon  
7/5/2024Braden Michael LeonardMajor ShareholderBuy123,017$1.15$141,469.5513,447,969View SEC Filing Icon  
7/3/2024Braden Michael LeonardMajor ShareholderBuy143,288$1.16$166,214.0813,324,952View SEC Filing Icon  
7/1/2024Braden Michael LeonardMajor ShareholderBuy107,434$1.14$122,474.7613,095,572View SEC Filing Icon  
6/27/2024Braden Michael LeonardMajor ShareholderBuy235,000$1.15$270,250.0011,787,134View SEC Filing Icon  
6/17/2024Braden Michael LeonardMajor ShareholderBuy150,000$1.13$169,500.0011,502,134View SEC Filing Icon  
6/13/2024Braden Michael LeonardMajor ShareholderBuy528,621$1.15$607,914.1511,007,134View SEC Filing Icon  
6/11/2024Braden Michael LeonardMajor ShareholderBuy1,000,000$1.08$1,080,000.0010,395,934View SEC Filing Icon  
10/23/2023Joseph MonahanInsiderSell6,000$5.08$30,480.00129,724View SEC Filing Icon  
8/28/2023James LoeropInsiderBuy14,705$6.80$99,994.0021,688View SEC Filing Icon  
8/21/2023Joseph MonahanInsiderSell6,000$7.32$43,920.00135,724View SEC Filing Icon  
6/20/2023Joseph MonahanInsiderSell6,000$10.28$61,680.00141,724View SEC Filing Icon  
3/9/2023Douglas J ManionCEOBuy6,500$7.74$50,310.006,500View SEC Filing Icon  
3/2/2023Joseph MonahanInsiderSell14,800$12.37$183,076.00151,261View SEC Filing Icon  
3/2/2023Kevin BalthaserCFOSell1,000$12.29$12,290.004,650View SEC Filing Icon  
3/2/2023Neal WalkerDirectorSell29,000$12.37$358,730.001,285,188View SEC Filing Icon  
2/8/2023James LoeropInsiderSell4,267$13.89$59,268.636,983View SEC Filing Icon  
1/3/2023Neal WalkerDirectorSell25,000$15.25$381,250.001,220,763View SEC Filing Icon  
12/15/2022Joseph MonahanInsiderSell5,000$15.88$79,400.0096,386View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Aclaris Therapeutics (NASDAQ:ACRS)

98.34% of Aclaris Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ACRS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Aclaris Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Susquehanna International Group LLP36,237$69K0.0%-70.1%0.033%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd544,760$1.04M0.0%+7.0%0.503%Search for SEC Filing on Google Icon
11/17/2025Palo Alto Investors LP1,566,840$2.98M0.6%+12.7%1.446%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC1,554,458$2.95M0.0%-59.5%1.435%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.42,755$81K0.0%-13.8%0.039%Search for SEC Filing on Google Icon
11/17/2025Bollard Group LLC1,225,476$2.33M0.1%-9.4%1.131%Search for SEC Filing on Google Icon
11/17/2025Citadel Advisors LLC1,432,677$2.72M0.0%+25.3%1.322%Search for SEC Filing on Google Icon
11/17/2025Algert Global LLC65,630$0.13M0.0%+64.7%0.061%Search for SEC Filing on Google Icon
11/17/2025Ameriprise Financial Inc.1,277,817$2.43M0.0%N/A1.179%Search for SEC Filing on Google Icon
11/14/2025Raymond James Financial Inc.283,476$0.54M0.0%+2.2%0.262%Search for SEC Filing on Google Icon
11/14/2025ADAR1 Capital Management LLC373,682$0.71M0.1%N/A0.345%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP368,107$0.70M0.0%-50.9%0.340%Search for SEC Filing on Google Icon
11/14/2025Bridgeway Capital Management LLC393,319$0.75M0.0%-11.3%0.363%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets26,667$51K0.0%+59.0%0.025%Search for SEC Filing on Google Icon
11/12/2025Dimensional Fund Advisors LP164,244$0.31M0.0%-20.8%0.152%Search for SEC Filing on Google Icon
11/12/2025Intech Investment Management LLC38,944$74K0.0%-12.9%0.036%Search for SEC Filing on Google Icon
11/10/2025Aldebaran Capital LLC987,698$1.88M1.7%-0.6%0.912%Search for SEC Filing on Google Icon
11/10/2025AXQ Capital LP13,969$27K0.0%N/A0.013%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.6,515,458$12.38M0.0%-2.2%6.014%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.758,576$1.44M0.0%+21.6%0.700%Search for SEC Filing on Google Icon
11/6/2025Rhumbline Advisers91,236$0.17M0.0%+7.4%0.084%Search for SEC Filing on Google Icon
11/3/2025New York State Common Retirement Fund48,400$92K0.0%-24.6%0.045%Search for SEC Filing on Google Icon
10/23/2025SG Americas Securities LLC22,012$42K0.0%-58.7%0.020%Search for SEC Filing on Google Icon
10/21/2025Three Bridge Wealth Advisors LLC714,823$1.36M0.4%N/A0.660%Search for SEC Filing on Google Icon
10/9/2025Voya Investment Management LLC17,248$33K0.0%-35.8%0.016%Search for SEC Filing on Google Icon
10/7/2025Assenagon Asset Management S.A.154,554$0.29M0.0%-16.3%0.143%Search for SEC Filing on Google Icon
8/27/2025Squarepoint Ops LLC390,583$0.56M0.0%+11.9%0.361%Search for SEC Filing on Google Icon
8/15/2025Engineers Gate Manager LP17,589$25K0.0%-56.3%0.016%Search for SEC Filing on Google Icon
8/15/2025Bridgeway Capital Management LLC443,319$0.63M0.0%+53.5%0.409%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE72,595$0.10M0.0%-56.7%0.067%Search for SEC Filing on Google Icon
8/14/2025Raymond James Financial Inc.277,259$0.39M0.0%+10.5%0.256%Search for SEC Filing on Google Icon
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.49,622$70K0.0%N/A0.046%Search for SEC Filing on Google Icon
8/14/2025The Manufacturers Life Insurance Company 34,131$48K0.0%N/A0.032%Search for SEC Filing on Google Icon
8/14/2025Qube Research & Technologies Ltd509,350$0.72M0.0%-62.3%0.470%Search for SEC Filing on Google Icon
8/14/2025Bollard Group LLC1,352,276$1.92M0.0%-5.0%1.248%Search for SEC Filing on Google Icon
8/13/2025Marshall Wace LLP2,292,449$3.26M0.0%-0.9%2.116%Search for SEC Filing on Google Icon
8/13/2025Stonepine Capital Management LLC491,300$0.70M0.7%-6.9%0.454%Search for SEC Filing on Google Icon
8/13/2025Invesco Ltd.135,329$0.19M0.0%+137.1%0.125%Search for SEC Filing on Google Icon
8/13/2025New York State Common Retirement Fund64,200$91K0.0%N/A0.059%Search for SEC Filing on Google Icon
8/12/2025XTX Topco Ltd23,917$34K0.0%N/A0.022%Search for SEC Filing on Google Icon
8/12/2025JPMorgan Chase & Co.623,792$0.89M0.0%+25.1%0.576%Search for SEC Filing on Google Icon
8/8/2025Intech Investment Management LLC44,731$64K0.0%N/A0.041%Search for SEC Filing on Google Icon
8/8/2025Police & Firemen s Retirement System of New Jersey19,700$28K0.0%N/A0.018%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC2,464,779$3.50M0.0%+108.4%2.276%Search for SEC Filing on Google Icon
8/7/2025ProShare Advisors LLC18,613$26K0.0%N/A0.017%Search for SEC Filing on Google Icon
8/7/2025Acadian Asset Management LLC2,433,850$3.45M0.0%+10.9%2.248%Search for SEC Filing on Google Icon
8/7/2025Connor Clark & Lunn Investment Management Ltd.797,134$1.13M0.0%-7.8%0.736%Search for SEC Filing on Google Icon
7/14/2025CRA Financial Services LLC17,782$25K0.0%N/A0.016%Search for SEC Filing on Google Icon
7/11/2025Assenagon Asset Management S.A.184,585$0.26M0.0%-72.9%0.170%Search for SEC Filing on Google Icon
6/27/2025Goldman Sachs Group Inc.555,953$0.85M0.0%+29.7%0.513%Search for SEC Filing on Google Icon
5/21/2025Acadian Asset Management LLC2,195,191$3.36M0.0%+25.9%2.027%Search for SEC Filing on Google Icon
5/19/2025Jane Street Group LLC390,282$0.60M0.0%-30.9%0.360%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.555,953$0.85M0.0%+29.7%0.513%Search for SEC Filing on Google Icon
5/16/2025Millennium Management LLC4,134,148$6.33M0.0%+111.0%3.818%Search for SEC Filing on Google Icon
5/16/2025Jacobs Levy Equity Management Inc.460,842$0.71M0.0%-20.0%0.426%Search for SEC Filing on Google Icon
5/15/2025Palo Alto Investors LP776,028$1.19M0.2%+36.2%0.717%Search for SEC Filing on Google Icon
5/15/2025Cubist Systematic Strategies LLC86,348$0.13M0.0%-66.3%0.080%Search for SEC Filing on Google Icon
5/15/2025State of Wyoming46,861$72K0.0%N/A0.043%Search for SEC Filing on Google Icon
5/15/2025OMERS ADMINISTRATION Corp175,900$0.27M0.0%+223.3%0.162%Search for SEC Filing on Google Icon
5/14/2025Stonepine Capital Management LLC527,842$0.81M0.8%-20.4%0.487%Search for SEC Filing on Google Icon
5/14/2025Walleye Capital LLC311,712$0.48M0.0%-56.6%0.288%Search for SEC Filing on Google Icon
5/13/2025Algert Global LLC39,850$61K0.0%N/A0.037%Search for SEC Filing on Google Icon
5/13/2025Aldebaran Capital LLC1,007,958$1.54M1.5%-0.9%0.931%Search for SEC Filing on Google Icon
5/13/2025HighTower Advisors LLC316,064$0.48M0.0%+20.2%0.292%Search for SEC Filing on Google Icon
5/12/2025Invesco Ltd.57,079$87K0.0%+409.0%0.053%Search for SEC Filing on Google Icon
5/12/2025Connor Clark & Lunn Investment Management Ltd.865,011$1.32M0.0%-4.8%0.799%Search for SEC Filing on Google Icon
5/8/2025Decheng Capital LLC4,041,736$6.18M1.7%+78.3%3.733%Search for SEC Filing on Google Icon
4/30/2025Alps Advisors Inc.78,782$0.12M0.0%+36.4%0.073%Search for SEC Filing on Google Icon
4/28/2025Cannon Global Investment Management LLC37,400$57K0.1%N/A0.035%Search for SEC Filing on Google Icon
4/15/2025Assenagon Asset Management S.A.681,553$1.04M0.0%+71.5%0.632%Search for SEC Filing on Google Icon
2/27/2025Jefferies Financial Group Inc.40,700$0.10M0.0%+253.9%0.057%Search for SEC Filing on Google Icon
2/18/2025Alpine Global Management LLC15,340$38K0.0%N/A0.021%Search for SEC Filing on Google Icon
2/17/2025Velan Capital Investment Management LP27,000$67K0.1%N/A0.038%Search for SEC Filing on Google Icon
2/17/2025Squarepoint Ops LLC292,892$0.73M0.0%+108.3%0.410%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Advisers LP977,400$2.42M0.0%-24.9%1.368%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Investments LP839,270$2.08M0.0%-7.6%1.175%Search for SEC Filing on Google Icon
2/17/2025Stonepine Capital Management LLC663,405$1.65M1.3%-73.0%0.929%Search for SEC Filing on Google Icon
2/17/2025Man Group plc53,534$0.13M0.0%N/A0.075%Search for SEC Filing on Google Icon
2/17/2025OMERS ADMINISTRATION Corp54,400$0.14M0.0%N/A0.076%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC1,959,047$4.86M0.0%-34.8%2.743%Search for SEC Filing on Google Icon
2/17/2025Jacobs Levy Equity Management Inc.576,042$1.43M0.0%-37.1%0.806%Search for SEC Filing on Google Icon
2/17/2025Janus Henderson Group PLC2,799,759$6.99M0.0%N/A3.920%Search for SEC Filing on Google Icon
2/17/2025Jefferies Financial Group Inc.40,700$0.10M0.0%+253.9%0.057%Search for SEC Filing on Google Icon
2/17/2025Graham Capital Management L.P.14,172$35K0.0%N/A0.020%Search for SEC Filing on Google Icon
2/17/2025D. E. Shaw & Co. Inc.3,293,625$8.17M0.0%-2.3%4.611%Search for SEC Filing on Google Icon
2/17/2025Cubist Systematic Strategies LLC256,092$0.64M0.0%+3,573.7%0.359%Search for SEC Filing on Google Icon
2/17/2025Bridgeway Capital Management LLC281,119$0.70M0.0%+41.2%0.394%Search for SEC Filing on Google Icon
2/17/2025Cantor Fitzgerald L. P.100,000$0.25M0.0%N/A0.140%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE205,465$0.51M0.0%+2,246.3%0.288%Search for SEC Filing on Google Icon
2/17/2025683 Capital Management LLC217,265$0.54M0.0%N/A0.304%Search for SEC Filing on Google Icon
2/14/2025RA Capital Management L.P.4,666,667$11.57M0.2%N/A6.533%Search for SEC Filing on Google Icon
2/14/2025Monashee Investment Management LLC888,888$2.20M0.3%N/A1.244%Search for SEC Filing on Google Icon
2/14/2025Samsara BioCapital LLC2,385,060$5.92M0.8%+242.6%3.339%Search for SEC Filing on Google Icon
2/14/2025Schonfeld Strategic Advisors LLC131,895$0.33M0.0%N/A0.185%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp175,175$0.43M0.0%+37.7%0.245%Search for SEC Filing on Google Icon
2/14/2025Decheng Capital LLC2,266,667$5.62M1.2%N/A3.173%Search for SEC Filing on Google Icon
2/14/2025Boothbay Fund Management LLC112,484$0.28M0.0%N/A0.157%Search for SEC Filing on Google Icon
2/14/2025Adage Capital Partners GP L.L.C.9,627,304$23.88M0.0%N/A13.478%Search for SEC Filing on Google Icon
2/14/2025Price T Rowe Associates Inc. MD123,100$0.31M0.0%-11.7%0.172%Search for SEC Filing on Google Icon
2/14/2025Alpine Global Management LLC15,340$38K0.0%N/A0.021%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Aclaris Therapeutics logo
Aclaris Therapeutics, Inc. a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. The company operates through two segments, Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment provides laboratory services. It develops Zunsemetinib (ATI-450), an MK2 inhibitor which is under Phase 1b/2 trials for the treatment of metastatic breast and pancreatic cancer; ATI-1777, a soft JAK 1/3 inhibitor, completed Phase 2b trails for the treatment of moderate to severe atopic dermatitis and other dermatologic conditions; and ATI-2138, an oral covalent inhibitor of ITK and JAK3 inhibitor under Phase 1 trials as a treatment for T cell-mediated autoimmune diseases. The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.
Read More on Aclaris Therapeutics

Today's Range

Now: $3.01
Low: $2.72
High: $3.08

50 Day Range

MA: $2.29
Low: $1.81
High: $3.01

52 Week Range

Now: $3.01
Low: $1.05
High: $4.03

Volume

1,616,426 shs

Average Volume

1,181,652 shs

Market Capitalization

$326.13 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.62

Who are the company insiders with the largest holdings of Aclaris Therapeutics?

Aclaris Therapeutics' top insider shareholders include:
  1. Braden Michael Leonard (Major Shareholder)
  2. Anand Mehra (Director)
Learn More about top insider investors at Aclaris Therapeutics.

Who are the major institutional investors of Aclaris Therapeutics?

Aclaris Therapeutics' top institutional investors include:
  1. Vanguard Group Inc. — 6.01%
  2. Palo Alto Investors LP — 1.45%
  3. Millennium Management LLC — 1.43%
  4. Citadel Advisors LLC — 1.32%
  5. Ameriprise Financial Inc. — 1.18%
  6. Bollard Group LLC — 1.13%
Learn More about top institutional investors of Aclaris Therapeutics stock.

Which major investors are selling Aclaris Therapeutics stock?

Within the last quarter, ACRS stock was sold by these institutional investors:
  1. Millennium Management LLC
  2. Two Sigma Investments LP
  3. Vanguard Group Inc.
  4. Bollard Group LLC
  5. Susquehanna International Group LLP
  6. Bridgeway Capital Management LLC
  7. Dimensional Fund Advisors LP
  8. SG Americas Securities LLC

Which major investors are buying Aclaris Therapeutics stock?

During the previous quarter, ACRS stock was purchased by institutional investors including:
  1. Ameriprise Financial Inc.
  2. Three Bridge Wealth Advisors LLC
  3. ADAR1 Capital Management LLC
  4. Citadel Advisors LLC
  5. Palo Alto Investors LP
  6. JPMorgan Chase & Co.
  7. Qube Research & Technologies Ltd
  8. Algert Global LLC
During the previous year, these company insiders have bought Aclaris Therapeutics stock:
  1. Braden Michael Leonard (Major Shareholder)
  2. Anand Mehra (Director)
Learn More investors buying Aclaris Therapeutics stock.